CD44, the surface receptor regulating cancer cell adhesion critical for colonization and invasion [29], also markedly increased with tumor injection, as shown in the PBS and dKLA groups compared to that in the WT group, whereas this increase was inhibited by TAMpep or TAMpepK treatment. This evidence concerns the gene CD44 and neoplasm.